Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: A randomized controlled trial

British Journal of Anaesthesia

Volumn 112, Issue 6, 2014, Pages 1055-1064

  Wang, Z X ^a   Huang, C Y ^a   Hua, Y P ^a   Huang, W Q ^a   Deng, L H ^a   Liu, K X ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

dexmedetomidine; hepatectomy; intestines; reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINE OXIDASE (COPPER CONTAINING); ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CISATRACURIUM; CREATINE KINASE MB; CREATININE; DEXMEDETOMIDINE; FENTANYL; HYDROCORTISONE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LACTIC ACID; MALONALDEHYDE; PROPOFOL; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOPULMONARY FUNCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENERAL ANESTHESIA; HEART RATE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTESTINE FUNCTION; INTESTINE INJURY; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; LIVER INJURY; LIVER RESECTION; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UREA NITROGEN BLOOD LEVEL;

DEXMEDETOMIDINE; HEPATECTOMY; INTESTINES; REPERFUSION INJURY;

ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); ANALGESICS, NON-NARCOTIC; ANESTHESIA, GENERAL; BIOLOGICAL MARKERS; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; FEMALE; HEPATECTOMY; HUMANS; INTESTINAL DISEASES; INTESTINES; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPERFUSION INJURY;

EID: 84901058404     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu132     Document Type: Article

References (33)

1. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860-9; discussion 9-70
2. van der Bilt JD, Livestro DP, Borren A, van Hillegersberg R, Borel Rinkes IH. European survey on the application of vascular clamping in liver surgery. Dig Surg 2007; 24: 423-35
3. Liu DL, Jeppsson B, Hakansson CH, Odselius R. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 1996; 131: 442-7 (Pubitemid 26113437)
4. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-59 (Pubitemid 46588419)
5. Dello SA, ReisingerKW, vanDamRM, et al. Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. Plos One 2012; 7: E30539
6. Erenoglu B, Gokturk HS, Kucukkartallar T, et al. Mechanical intestinal cleansing and antibiotic prophylaxis for preventing bacterial translocation during the Pringle maneuver in rabbits. Surg Today 2011; 41: 824-8
7. Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury-and shock induced SIRS and MODS: The gut-lymph hypothesis, a review. Front Biosci 2006; 11: 520-8 (Pubitemid 43258161)
8. Rotstein OD.Pathogenesis of multiple organdysfunction syndrome: Gut origin, protection, and decontamination. Surg Infect 2000; 1: 217-23; discussion 23-5
9. Dahmani S, Rouelle D, Gressens P, Mantz J. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology 2005; 103: 969-77 (Pubitemid 41552052)
10. Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: A histopathologic study. Renal Fail 2009; 31: 70-4
11. Engelhard K,Werner C, Eberspacher E, et al. The effect of the alpha 2-agonistdexmedetomidine and theN-methyl-D-aspartate antagonist S(+)-ketamineonthe expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003; 96: 524-31, table of contents (Pubitemid 36125776)
12. OkadaH, Kurita T, Mochizuki T, Morita K, Sato S. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Resuscitation 2007; 74: 538-45 (Pubitemid 47176759)
13. Arcangeli A, D'Alo C, Gaspari R. Dexmedetomidine use in general anaesthesia. Curr Drug Targets 2009; 10: 687-95
14. TufekA, TokgozO,Aliosmanoglu I, et al. Theprotective effects ofdexmedetomidineontheliverandremoteorgansagainsthepatic ischemia reperfusion injury in rats. Int J Surg 2013; 11: 96-100
15. Sahin T, Begec Z, Toprak HI, et al. The effects of dexmedetomidine on liver ischemia-reperfusion injury in rats. J Surg Res 2013; 183: 385-90
16. Yeh YC, Sun WZ, Ko WJ, et al. Dexmedetomidine prevents alterations of intestinal microcirculation that are induced by surgical stress andpain ina novel rat model.Anesth Analg 2012;115: 46-53
17. Zhang X-Y, Liu Z-M,Wen S-H, et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology 2012; 116: 1035-46
18. Wolvekamp MC, de Bruin RW. Diamine oxidase: An overview of historical, biochemical and functional aspects. Digest Dis (Basel, Switzerland) 1994; 12: 2-14
19. Song JC, Sun YM, Yang LQ, Zhang MZ, Lu ZJ, Yu WF. A comparison of liver function after hepatectomy with inflow occlusion between sevoflurane and propofol anesthesia. Anesth Analg 2010; 111: 1036-41
20. Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: The effect on recovery outcome variables. Anesth Analg 2008; 106: 1741-8
21. Blaudszun G, Lysakowski C, Elia N, Tramè rMR. Effect of perioperative systemic a2 agonists on postoperative morphine consumption and pain intensity: Systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2012; 116: 1312-22
22. Gurbet A, Basagan-Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth 2006; 53: 646-52 (Pubitemid 44262821)
23. Li C, Li YS, Xu M, et al. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: A randomized controlled trial. Anesthesiology 2013; 118: 842-52
24. Reintam A, Parm P, Kitus R, Starkopf J, Kern H. Gastrointestinal failure score in critically ill patients: A prospective observational study. Crit Care 2008; 12: R90
25. Lerman J. Study design in clinical research: Sample size estimation and power analysis. Can J Anaesth 1996; 43: 184-91 (Pubitemid 26111481)
26. Arii S, Teramoto K, Kawamura T. Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver. J Hepatobiliary Pancreat Surg 2003; 10: 189-94 (Pubitemid 37407502)
27. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006; 244: 921-8; discussion 8-30 (Pubitemid 44808626)
28. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg 2010; 97: 1461-75
29. Liu KX, Li YS, Huang WQ, Li C, Liu JX, Li Y. Immediate but not delayed postconditioning during reperfusion attenuates acute lung injury induced by intestinal ischemia/reperfusion in rats: Comparison with ischemic preconditioning. J Surg Res 2009; 157: E55-62
30. Liu KX, Li YS, Huang WQ, et al. Immediate postconditioning during reperfusion attenuates intestinal injury. Intensive Care Med 2009; 35: 933-42
31. Hall SR,Wang L, Milne B,HongM. Central dexmedetomidine attenuates cardiacdysfunction inarodentmodelof intracranialhypertension. Can J Anaesth 2004; 51: 1025-33 (Pubitemid 40104121)
32. Si Y, Bao H, Han L, et al. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation. J Transl Med 2013; 11: 141
33. Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011; 15: 153